🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of study is to evaluate the efficacy and safety of 1 year dur...
Status
Recruiting
Location
Wonju Severance Christian Hospital
Start Date
2022-05-13
Trial ID
NCT06075433
The objective of this study is to evaluate the efficacy and safety of the G...
Status
Completed
Location
Korea University Guro Hospital
Start Date
2017-06-24
Trial ID
NCT06066476
This study aims to evaluate the efficacy and safety of abluminal biodegrada...
Status
Recruiting
Location
Cardiac and Vascular Center; Samsung Medical Center
Start Date
2022-04-24
Trial ID
NCT05444452
The objective of study is to evaluate the efficacy and safety of short dura...
Status
Recruiting
Location
Wonju Severance Christian Hospital
Start Date
2021-08-18
Trial ID
NCT06075420
The investigators intend to establish a multicenter prospective observation...
Status
Enrolling By Invitation
Location
Korea University GURO Hospital
Start Date
2023-11-15
Trial ID
NCT06168305
Treatments Being Tested
In this study, the investigators evaluated the effectiveness and safety of ...
Status
Enrolling By Invitation
Location
Korea University Anam Hospital
Start Date
2022-07-15
Trial ID
NCT06086496
Treatments Being Tested
The purpose of this observational study is to evaluate the long-term effect...
Status
Recruiting
Location
Ajou University Hospital
Start Date
2023-07-07
Trial ID
NCT06066450
Treatments Being Tested
Efficacy and Safety of GENOSS SES in patients with coronary artery disease...
Status
Active Not Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2018-04-19
Trial ID
NCT06841510
The objective of this study is to evaluate the efficacy and safety of the G...
Status
Active Not Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2020-03-16
Trial ID
NCT06075368
Treatments Being Tested